May 14, 2026
GHRP-2 Growth Hormone Research: Key Study Findings
Explore preclinical GHRP-2 growth hormone research: GHSR-1a agonism, GH pulse amplitude, ghrelin mimicry, and synergy with GHRH analogs in animal models.
RESEARCH NOTES
May 14, 2026
Explore preclinical GHRP-2 growth hormone research: GHSR-1a agonism, GH pulse amplitude, ghrelin mimicry, and synergy with GHRH analogs in animal models.
May 14, 2026
Explore Ipamorelin GHRP mechanisms, GHSR-1a receptor agonism, selectivity data, and 2022–2025 preclinical research findings in this expert research overview.
May 13, 2026
Preclinical research on blood-brain barrier peptide transport: BBB structure, exclusion mechanisms, and CNS-penetrant peptides Selank, Semax, and Pinealon.
May 13, 2026
Explore preclinical research on NAD+ DNA repair mechanisms, PARP-1 enzyme activity, and NAD+ depletion in aged animal tissues. Strictly for research contexts.
May 13, 2026
Pinealon vs Epithalon: a preclinical comparison of two Khavinson bioregulator peptides — mechanisms, study models, epigenetic effects, and key differences.
May 13, 2026
CJC-1295 vs Tesamorelin: compare GHRH analog structures, half-lives, GH pulse patterns, IGF-1 profiles, and body composition findings in preclinical models.
May 13, 2026
Explore Melanotan-2 CNS research: MC3R/MC4R expression, neuroprotection in TBI and ischemia models, microglial NF-κB suppression, and oxidative stress data.
May 13, 2026
Semax BDNF research: rodent brain models, VEGF expression, MCAO stroke data, and melanocortin receptor mechanisms reviewed from peer-reviewed literature.
May 13, 2026
Retatrutide triple agonist research: GLP-1R, GIPR, and glucagon receptor mechanisms, Phase 2 NEJM 2023 trial data, and preclinical metabolic comparisons.
May 13, 2026
Explore MOTS-c as an exercise mimetic in preclinical research: AMPK activation, GLUT4 translocation, PGC-1α upregulation, and metabolic effects in rodent models